Ftse Mib
34.315,24
-1,22%
DAX
20.246,37
-0,33%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
103.564,16
-2,44%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE AbbVie Inc (ABBV) AbbVie Inc (ABBV) Notizie

AbbVie Inc

ABBV
175,00
3,37 (1,96%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/12/202423:34EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:05EDGAR2Form 8-K - Current report
13/12/202415:15PRNUSAbbVie to Acquire Nimble Therapeutics, Further Strengthening..
11/12/202415:15PRNUSAbbVie Completes Acquisition of Aliada Therapeutics
09/12/202418:00PRNUSTwo Data Analyses From Clinical Trials Show Epcoritamab..
09/12/202414:00PRNUSAbbVie Announces Positive Topline Results for the Phase 3..
08/12/202421:00PRNUSAbbVie Announces Emotional Impact Report on Mental Health of..
08/12/202401:00PRNUSInvestigational Epcoritamab (DuoBody® CD3xCD20) Combination..
25/11/202414:00PRNUSAbbVie to Present at Citi's 2024 Global Healthcare..
18/11/202415:00PRNUSAllergan Aesthetics Offers Free Business Education Courses..
18/11/202407:00PRNUSAbbVie Receives European Commission Approval of ELAHERE®..
14/11/202414:15PRNUSAbbVie Awards 20 Individuals Living With Migraine To Support..
11/11/202414:30PRNUSAbbVie Provides Update on Phase 2 Results for Emraclidine in..
07/11/202414:00PRNUSAllergan Aesthetics Celebrates Annual BOTOX® Cosmetic..
04/11/202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/11/202420:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202411:55IHMARKETNEWSAmazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising..
31/10/202413:00GLOBEAbbVie and EvolveImmune Therapeutics Announce Collaboration..
31/10/202413:00PRNUSAbbVie and EvolveImmune Therapeutics Announce Collaboration..
30/10/202412:43EDGAR2Form 8-K - Current report
30/10/202412:38PRNUSAbbVie Reports Third-Quarter 2024 Financial Results
29/10/202413:00PRNCAAbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in..
28/10/202413:00PRNUSAbbVie to Acquire Aliada Therapeutics, Strengthening Focus..
24/10/202417:30PRNUSAbbVie and Gedeon Richter Announce New Collaboration for the..
21/10/202414:00PRNCANine Provinces Approve Accelerated Public Reimbursement of..
19/10/202401:44PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval..
17/10/202414:00PRNUSU.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for..
16/10/202414:00PRNUSAllergan Aesthetics to Present New Data at 2024 American..
04/10/202415:00PRNUSAllergan Aesthetics and Girls Inc. Celebrate Six Years and..
03/10/202422:07EDGAR2Form 8-K - Current report
02/10/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202415:00IHNWTransforming Alzheimer's Treatment: Innovative Combinations..
02/10/202414:00PRNUSAvailable Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to..
01/10/202414:00PRNUSAbbVie to Host Third-Quarter 2024 Earnings Conference Call
30/9/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202418:13PRNUSAbbVie Submits Biologics License Application to the FDA for..
26/9/202414:00PRNUSAbbVie Announces Positive Topline Results from Phase 3..
25/9/202413:00PRNUSNew Analysis Demonstrates the Efficacy of RINVOQ®..
24/9/202414:00PRNUSEmpowering Women Entrepreneurs: 2024 BOTOX®..
20/9/202413:32PRNUSAbbVie Receives Positive CHMP Opinion for Mirvetuximab..
11/9/202414:30PRNUSAllergan Aesthetics Launches BOTOX® Cosmetic..
10/9/202421:30EDGAR2Form 8-K - Current report
10/9/202413:00PRNCAHealth Canada Approves AbbVie's CONSTELLA® (linaclotide) for..
09/9/202415:00PRNUSAbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO..
06/9/202416:13PRNUSAbbVie Declares Quarterly Dividend
04/9/202414:00PRNCAAbbVie reçoit une recommandation favorable de la part de..
27/8/202414:15PRNUSAbbVie Awards Scholarships to 45 U.S. Students Living With..
27/8/202414:05PRNUSSkinMedica® Revolutionizes Skin Hydration with the..
19/8/202420:05PRNUSEuropean Commission Grants Second Indication Approval for..
Apertura: 170,58 Min: 170,21 Max: 176,50
Chiusura: 171,63

La tua Cronologia

NYSE
ABBV
AbbVie
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network